In patients allocated blindly and randomly to receive bitemporal, right unilateral, or bifrontal electroconvulsive therapy, seizure length, electrophysiologic characteristics (dynamic impedance, seizure threshold, and changes in threshold), and the degree of suprathreshold stimulation were recorded. The relations of these variables to clinical outcome and cognitive effects were determined. There were no differences in seizure length between groups, and there were no significant correlations between seizure length and any measure of clinical response. There were substantial differences between the groups in mean charge per treatment, with the right unilateral group receiving lower doses than either bilateral group. Convulsion time was inversely related to applied charge and the rate of increase in charge. There were no significant correlations between impedance, charge, energy, or rate of increase in charge on the one hand, and clinical improvement on the other. The increase in threshold during the course of treatment was not related to clinical change. Cognitive impairment was related to electrical dose only in the bifrontal group, which showed the least degree of treatment-induced intellectual dysfunction. Compared with bitemporal or right unilateral treatment, bifrontal electroconvulsive therapy yields the best ratio of benefits to side effects and should be given at threshold level to minimize cognitive loss.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00124509-200012000-00006DOI Listing

Publication Analysis

Top Keywords

bitemporal unilateral
12
seizure length
12
electrical dose
8
seizure threshold
8
clinical outcome
8
outcome cognitive
8
cognitive effects
8
bifrontal electroconvulsive
8
electroconvulsive therapy
8
rate increase
8

Similar Publications

A Case of Ischemic Pituitary Apoplexy Secondary to ACTH-Secreting Macroadenoma.

Neurohospitalist

October 2024

Neurosurgery Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Article Synopsis
  • - Pituitary apoplexy (PA) is a serious complication of pituitary adenomas, causing symptoms like sudden headaches, nausea, vision changes, and nerve paralysis, which can lead to diagnostic delays due to their non-specific nature.
  • - A case study describes a 73-year-old man with an ACTH-secreting macroadenoma who experienced rapid symptoms, including headaches and eye paralysis, requiring urgent surgery and resulting in near-total recovery.
  • - PA's unusual presentation of bilateral ptosis and ophthalmoplegia emphasizes the importance of recognizing these rare symptoms, as prompt treatment can significantly improve patient outcomes, as illustrated by this case's success in managing ischemic PA without hemorrhage.
View Article and Find Full Text PDF

Introduction: Electroconvulsive therapy (ECT) is effective in treating severe depression and other neuropsychiatric disorders, but how the presence of an anatomical anomaly affects the electrical pathways between the electrodes remains unclear. We investigate the difference in electric field (E-field) distribution during ECT in the brain of a patient with an arachnoid cyst relative to hypothetical condition where the cyst was not present.

Methods: Magnetic resonance imaging scans of the head of a patient with a large left frontal cyst were segmented to construct a finite element model to study the E-field distribution during ECT.

View Article and Find Full Text PDF

Atypical Presentations of Hydroxychloroquine Retinopathy: A Case Series Study.

J Clin Med

June 2024

Department of Ophthalmology, Hanyang University Hospital, Hanyang University College of Medicine, Seoul 04763, Republic of Korea.

Hydroxychloroquine retinopathy, traditionally characterized by parafoveal or pericentral outer retinal damage, is explored for atypical presentations in Asian patients. This challenges conventional beliefs regarding onset, retinopathy pattern, and associated visual field defects. Ninety-five patients diagnosed with hydroxychloroquine retinopathy at Hanyang University Hospital underwent screening from January 2010 to December 2023.

View Article and Find Full Text PDF

Electroconvulsive therapy (ECT) pulse amplitude, which dictates the induced electric field (E-field) magnitude in the brain, is presently fixed at 800 or 900 milliamperes (mA) without clinical or scientific rationale. We have previously demonstrated that increased E-field strength improves ECT's antidepressant effect but worsens cognitive outcomes. Amplitude-determined seizure titration may reduce the E-field variability relative to fixed amplitude ECT.

View Article and Find Full Text PDF

Electroconvulsive Therapy Across Nations: A 2022 Survey of Practice.

J ECT

June 2024

From the Noninvasive Neuromodulation Unit, Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, Bethesda.

Objectives: We aimed to characterize worldwide electroconvulsive therapy (ECT) practice and compare practice across nations and global regions.

Method: Our anonymous survey was open on SurveyMonkey.com from January to June 2022.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!